Description

In this episode of Anesthesia Alchemy, Garry and Terry briefly discuss the history, physiology, and pharmacology of using non-depolarizing neuromuscular blocking drugs as anesthesia adjuncts. They focus on the pitfalls of administrating these agents to surgical patients and the problems associated with residual neuromuscular blockade in the post-anesthesia care unit.

Here’s some of what we discuss in this episode:

• What are cyclodextrins and why are they useful?
• Understanding the essentials of neuromuscular transmission.
• What some of the newer intermediate-acting neuromuscular drugs do and how they work.
• How the treatment has changed through the years.
• Monitoring recovery from neuromuscular blockade.
• Running through the eight recommendations that were published.

Visit us online and get show references here: https://beyondthemaskpodcast.com/

Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf

Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246